nandrolone has been researched along with Recrudescence in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Akira, S; Matsushima, T; Takeshita, T; Yoneyama, K | 1 |
| Ceccarello, M; Ceccaroni, M; Clarizia, R; Donati, A; Ferrero, S; Liverani, S; Manzone, M; Roviglione, G | 1 |
| Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S | 1 |
| Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW | 1 |
| Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H | 1 |
| Jee, BC; Jeong, SH; Kim, SK; Lee, D | 1 |
| Cho, S; Kim, SH; Lee, DY; Lee, JH; Lee, SR; Seo, SK; Shin, JH; Song, JY; Yi, KW | 1 |
| Akiyama, K; Ito, F; Kataoka, H; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Okimura, H; Takaoka, O | 1 |
| Arakawa, T; Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Koga, K; Ma, S; Nagashima, N; Neriishi, K; Osuga, Y; Sun, H; Wada-Hiraike, O | 1 |
| Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Triolo, O | 1 |
| Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A | 1 |
| Isaka, K; Kato, R; Kojima, J; Nagamitsu, Y; Nishi, H; Sasaki, T; Takaesu, Y | 1 |
| Choi, D; Lee, DY; Lee, JY; Seo, JW; Yoon, BK | 1 |
| Alfaraj, S; Allaire, C; Bedaiwy, MA | 1 |
| Domschke, W; Heinig, J; Lerch, MM; Simon, P; Weiss, FU; Zimmer, KP | 1 |
| Breckwoldt, M | 1 |
| Bentley-Phillips, CB; Cooper, RC; Hallett, AF | 1 |
1 review(s) available for nandrolone and Recrudescence
| Article | Year |
|---|---|
Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
Topics: Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Medication Adherence; Nandrolone; Pelvic Pain; Progestins; Recurrence; Treatment Outcome; Young Adult | 2017 |
3 trial(s) available for nandrolone and Recrudescence
| Article | Year |
|---|---|
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intestines; Laparoscopy; Leuprolide; Nandrolone; Pelvic Pain; Peritoneum; Postoperative Care; Pregnancy; Recurrence; Reoperation; Secondary Prevention; Treatment Outcome; Triptorelin Pamoate | 2021 |
Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
Topics: Adolescent; Adult; Drug Combinations; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Italy; Laparoscopy; Middle Aged; Nandrolone; Pain Management; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires | 2015 |
Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
Topics: Adult; Conservative Treatment; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormone Antagonists; Humans; Nandrolone; Pain; Postoperative Care; Prospective Studies; Recurrence; Secondary Prevention | 2016 |
13 other study(ies) available for nandrolone and Recrudescence
| Article | Year |
|---|---|
Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Topics: Adenomyosis; Adult; Cohort Studies; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Middle Aged; Nandrolone; Recurrence; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2020 |
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2017 |
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence | 2018 |
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
Topics: Adult; Alopecia; Cross-Sectional Studies; Depression; Endometriosis; Female; Humans; Menstruation; Menstruation Disturbances; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Quality of Life; Recurrence; Republic of Korea; Surveys and Questionnaires; Time Factors; Weight Gain | 2018 |
Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
Topics: Adult; Amenorrhea; CA-125 Antigen; Endometriosis; Female; Hormone Antagonists; Humans; Multicenter Studies as Topic; Nandrolone; Pain; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome | 2018 |
Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Recurrence; Reoperation; Young Adult | 2018 |
Clinical aspects and management of inguinal endometriosis: A case series of 20 patients.
Topics: Adult; Endometriosis; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Inguinal Canal; Magnetic Resonance Imaging; Middle Aged; Nandrolone; Recurrence; Retrospective Studies | 2019 |
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies | 2016 |
Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
Topics: Adult; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nandrolone; Pelvic Pain; Recurrence | 2016 |
Treatment of menstruation-associated recurrence of hereditary pancreatitis with pharmacologic ovarian suppression.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Estradiol; Female; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Menstrual Cycle; Nandrolone; Ovary; Pancreatitis; Recurrence; Risk Assessment; Treatment Outcome | 2002 |
[Hormone use in migraine].
Topics: Adult; Chronic Disease; Contraceptives, Oral; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Migraine Disorders; Nandrolone; Ovulation Inhibition; Recurrence; Time Factors | 2003 |
Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis.
Topics: Adrenal Cortex Hormones; Bacterial Infections; Clofazimine; Humans; In Vitro Techniques; Levamisole; Male; Middle Aged; Nandrolone; Neutrophils; Phagocytosis; Pyoderma; Recurrence; Skin Ulcer; Testosterone | 1982 |